Here, we provide evidence from both in vitro and in vivo experiments, employing a wide range of GC cell lines, patient-derived tumor organoids (PDOs) as well as CDX and PDX xenograft models, to demonstrate that BCLXL and MCL1 are key for GC cell survival. Here, MCL1 is linked to neoplasm.